Sanofi grows partnerships

Wednesday 4 May 2022
Country

France

Sanofi SA increased sales and operating profit in the 2022 first quarter while taking steps to replenish its portfolio through new partnerships. The partnership deals ranged from a classic collaboration with Seagen Inc to develop antibody-drug conjugates to a more adventurous risk-sharing partnership with Blackstone Life Sciences to accelerate development of a subcutaneous formulation of its multiple myeloma treatment Sarclisa.